.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Merck
Mallinckrodt
Deloitte
Novartis
Accenture
Teva
AstraZeneca
UBS
McKinsey

Generated: February 21, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to France Patent: 00 10121

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Allergan Sales LlcAVYCAZavibactam sodium; ceftazidimePOWDER;IV (INFUSION)206494-001Feb 25, 2015RXYesYes➤ Sign Up➤ Sign UpYYMETHOD OF TREATING BACTERIAL INFECTIONS
Allergan Sales LlcAVYCAZavibactam sodium; ceftazidimePOWDER;IV (INFUSION)206494-001Feb 25, 2015RXYesYes➤ Sign Up➤ Sign UpYYMETHOD OF TREATING BACTERIAL INFECTIONS
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist